[1]
|
O. J. Dempsey, K. M. Kerr, H. Remmen and A. R. Denison, “How to Investigate a Patient with Suspected Interstitial Lung Disease,” British Medical Journal, Vol. 340, 2010, p. c2843. doi:10.1136/bmj.c2843
|
[2]
|
O. Eickelberg and M. Selman, “Update in Diffuse ParenChymal Lung Disease 2009,” American Journal of Respiratory and Critical Care Medicine, Vol. 181, No. 9, 2010, pp. 883-888. doi:10.1164/rccm.201001-0124UP
|
[3]
|
L. E. Vanfleteren and C. F. Linssen, “Role of MicroorgaNisms in Interstitial Lung Disease,” Current Opinion in Pulmonary Medicine, Vol. 16, No. 5, 2010, pp. 489-495.
doi:10.1097/MCP.0b013e32833b1c54
|
[4]
|
P. A. Wijnen, O. Bekers and M. Drent, “Relationship between Drug-Induced Interstitial Lung Diseases and CytoChrome p450 Polymorphisms,” Current Opinion in Pulmonary Medicine, Vol. 16, No. 5, 2010, pp. 496-502.
doi:10.1097/MCP.0b013e32833c06f1
|
[5]
|
M. Chopra, J. S. Reuben and A. C. Sharma, “Acute Lung Injury, Apoptosis and Signaling Mechanisms,” Experimental Biology and Medicine, Vol. 234, No. 4, 2009, pp. 361371. doi:10.3181/0811-MR-318
|
[6]
|
A. Bast, A. R. Weseler, G. R. Haenen and G. J. den Hartog, “Oxidative Stress and Antioxidants in Interstitial Lung Disease,” Current Opinion in Pulmonary Medicine, Vol. 16, No. 5, 2010, pp. 516-520.
doi:10.1097/MCP.0b013e32833c645d
|
[7]
|
J. W. Sam, S. Takahashi, I. Lippai, J. Peisach and D. L. Rousseau, “Sequence-Specific Changes in the Metal Site of Ferric Bleomycin Induced by the Binding of DNA,” Journal of Biological Chemistry, Vol. 273, No. 26, 1998, pp. 16090-16097. doi:10.1074/jbc.273.26.16090
|
[8]
|
J. Fukumoto, C. Harada, T. Kawaguchi, S. Suetsugu, T. Maeyama, I. Inoshima, N. Hamada, K. Kuwano and Y. Nakanishi, “Amphiregulin Attenuates Bleomycin-Induced Pneumopathy in Mice,” American Journal of Physiology —Lung Cellular and Molecular, Vol. 298, No. 2, 2010, pp. L131-138. doi:10.1152/ajplung.90576.2008
|
[9]
|
P. Camus, A. Fanton, P. Bonniaud, C. Camus and P. Foucher, “Interstitial Lung Disease Induced by Drugs and Radiation,” Respiration, Vol. 71, No. 4, 2004, pp. 301326. doi:10.1159/000079633
|
[10]
|
K. H. Lee and K. H. Rhee, “Radioprotective Effect of Cyclo(l-phenylalanyl-l-prolyl) on Irradiated Rat Lung,” Journal of Microbiology and Biotechnology, Vol. 18, No. 2, 2008, pp. 369-376.
|
[11]
|
B. Movsas, T. A. Raffin, A. H. Epstein and C. J. Link Jr., “Pulmonary Radiation Injury,” Chest, Vol. 111, No. 4, 1997, pp. 1061-1076. doi:10.1378/chest.111.4.1061
|
[12]
|
P. R. Graves, F. Siddiqui, M. S. Anscher and B. Movsas, “Radiation Pulmonary Toxicity. From Mechanisms to Management,” Seminars in Radiation Oncology, Vol. 20, No. 3, 2010, pp. 201-207.
doi:10.1016/j.semradonc.2010.01.010
|
[13]
|
G. Blander and L. Guarente, “The Sir2 Family of Protein Deacetylases,” Annual Review of Biochemistry, Vol. 73, 2004, pp. 417-435.
|
[14]
|
L. Bordone and L. Guarente, “Calorie Restriction, Sirt1 and Metabolism. Understanding Longevity,” Nature Reviews Molecular Cell Biology, Vol. 6, No. 4, 2005, pp. 298-305. doi:10.1038/nrm1616
|
[15]
|
C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, A. Bagdasarian, T. Tamakloe, W. J. Wang, X. Song, W. M. Chu, N. Kouttab, A. Xu and Y. Wan, “Sirt1 Confers Protection against Uvband h2o2-Induced Cell Death via Modulation of p53 and Jnk in Cultured Skin Keratinocytes,” Journal of Cellular and Molecular Medicine, Vol. 13, No. 96, 2009, pp. 3632-3643.
doi:10.1111/j.1582-4934.2008.00453.x
|
[16]
|
K. Hasegawa, S. Wakino, K. Yoshioka, S. Tatematsu, Y. Hara, H. Minakuchi, K. Sueyasu, N. Washida, H. Tokuyama, M. Tzukerman, K. Skorecki, K. Hayashi and H. Itoh, “Kidney-Specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function,” Journal of Biological Chemistry, Vol. 285, No. 17, 2010, pp. 13045-13056.
doi:10.1074/jbc.M109.067728
|
[17]
|
K. Ito, C. E. Charron and I. M. Adcock, “Impact of Protein Acetylation in Inflammatory Lung Diseases,” Pharmacology & Therapeutics, Vol. 116, No. 2, 2007, pp. 249-265. doi:10.1016/j.pharmthera.2007.06.009
|
[18]
|
J. T. Rodgers, C. Lerin, Z. Gerhart-Hines and P. Puigserver, “Metabolic Adaptations through the Pgc-1 Alpha and Sirt1 Pathways,” FEBS Letters, Vol. 582, No. 1, 2008, pp. 46-53.
|
[19]
|
J. H. Lim, Y. M. Lee, Y. S. Chun, J. Chen, J. E. Kim and J. W. Park, “Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1alpha,” Molecular Cell, Vol. 38, No. 6, 2010, pp. 864-878.
|
[20]
|
Z. Ungvari, N. Labinskyy, P. Mukhopadhyay, J. T. Pinto, Z. Bagi, P. Ballabh, C. Zhang, P. Pacher and A. Csiszar, “Resveratrol Attenuates Mitochondrial Oxidative Stress in Coronary Arterial Endothelial Cells,” American Journal of Physiology—Heart and Circulatory Physiology, Vol. 297, No. 5, 2009, pp. H1876-1881.
doi:10.1152/ajpheart.00375.2009
|
[21]
|
S. R. Yang, J. Wright, M. Bauter, K. Seweryniak, A. Kode and I. Rahman, “Sirtuin Regulates Cigarette Smoke-Induced Proinflammatory Mediator Release via rela/ p65 nf-Kappab in Macrophages in Vitro and in Rat Lungs in Vivo, Implications for Chronic Inflammation and Aging,” American Journal of Physiology—Lung Cellular and Molecular, Vol. 292, No. 2, 2007, pp. L567-576.
|
[22]
|
S. R. Kim, K. S. Lee, S. J. Park, K. H. Min, Y. H. Choe, H. Moon, W. H. Yoo, H. J. Chae, M. K. Han and Y. C. Lee, “Involvement of Sirtuin 1 in Airway Inflammation and Hyperresponsiveness of Allergic Airway Disease,” Journal of Allergy and Clinical Immunology, Vol. 125, No. 2, 2010, pp. 449-460. doi:10.1016/j.jaci.2009.08.009
|
[23]
|
J. C. Milne, P. D. Lambert, S. Schenk, D. P. Carney, J. J. Smith, D. J. Gagne, L. Jin, O. Boss, R. B. Perni, C. B. Vu, J. E. Bemis, R. Xie, J. S. Disch, P. Y. Ng, J. J. Nunes, A. V. Lynch, H. Yang, H. Galonek, K. Israelian, W. Choy, A. Iffland, S. Lavu, O. Medvedik, D. A. Sinclair, J. M. Olefsky, M. R. Jirousek, P. J. Elliott and C. H. Westphal, “Small Molecule Activators of Sirt1 as Therapeutics for the Treatment of Type 2 Diabetes,” Nature, Vol. 450, No. 7170, 2007, pp. 712-716. doi:10.1038/nature06261
|
[24]
|
Y. Yamazaki, I. Usui, Y. Kanatani, Y. Matsuya, K. Tsuneyama, S. Fujisaka, A. Bukhari, H. Suzuki, S. Senda, S. Imanishi, K. Hirata, M. Ishiki, R. Hayashi, M. Urakaze, H. Nemoto, M. Kobayashi and K. Tobe, “Treatment with Srt1720, a Sirt1 Activator, Ameliorates Fatty Liver with Reduced Expression of Lipogenic Enzymes in Msg Mice,” American Journal of Physiology—Endocrinology and Metabolism, Vol. 297, No. 5, 2009, pp. E1179-E1186.
doi:10.1152/ajpendo.90997.2008
|
[25]
|
T. Ashcroft, J. M. Simpson and V. Timbrell, “Simple Method of Estimating Severity of Pulmonary Fibrosis on a Numerical Scale,” Journal of Clinical Pathology, Vol. 41, No. 4, 1988, pp. 467-470. doi:10.1136/jcp.41.4.467
|
[26]
|
B. B. Moore and C. M. Hogaboam, “Murine Models of Pulmonary Fibrosis,” American Journal of Physiology— Lung Cellular and Molecular, Vol. 294, No. 2, 2008, pp. L152-160. doi:10.1152/ajplung.00313.2007
|
[27]
|
T. Fujita, M. Maruyama, J. Araya, K. Sassa, Y. Kawagishi, R. Hayashi, S. Matsui, T. Kashii, N. Yamashita, E. Sugiyama and M. Kobayashi, “Hydrogen Peroxide Induces Upregulation of Fas in Human Airway Epithelial Cells via the Activation of Parp-p53 Pathway,” American Journal of Respiratory Cell and Molecular Biology, Vol. 27, No. 5, 2002, pp. 542-552.
|
[28]
|
T. Yamada, M. Maruyama, T. Fujita, K. Miyabayashi, C. Shinoda, Y. Kawagishi, T. Fujishita, R. Hayashi, T. Miwa, N. Arai, S. Matsui, E. Sugiyama and M. Kobayashi, “Ionizing Radiation Suppresses Fap-1 Mrna Level in a549 Cells via p53 Activation,” FEBS Letters, Vol. 580, No. 18, 2006, pp. 4387-4391. doi:10.1016/j.febslet.2006.07.003
|
[29]
|
E. A. Sausville, J. Peisach and S. B. Horwitz, “A Role for Ferrous Ion and Oxygen in the Degradation of DNA by Bleomycin,” Biochemical and Biophysical Research Communications, Vol. 73, No. 3, 1976, pp. 814-822.
doi:10.1016/0006-291X(76)90882-2
|
[30]
|
S. Chung, H. Yao, S. Caito, J. W. Hwang, G. Arunachalam and I. Rahman, “Regulation of SIRT1 in Cellular Functions: Role of Polyphenols,” Archives of Biochemistry and Biophysics, Vol. 501, No. 1, 2010, pp. 79-90.
doi:10.1016/j.abb.2010.05.003
|
[31]
|
E. Maury, K. M. Ramsey and J. Bass, “Circadian Rhythms and Metabolic Syndrome: From Experimental Genetics to Human Disease,” Circulation Research, Vol. 106, No. 3, 2010, pp. 447-462.
doi:10.1161/CIRCRESAHA.109.208355
|
[32]
|
Y. Lu, N. Azad, L. Wang, A. K. Iyer, V. Castranova, B. H. Jiang and Y. Rojanasakul, “Phosphatidylinositol-3-kinase/ akt Regulates Bleomycin-Induced Fibroblast Proliferation and Collagen Production,” American Journal of Respiratory Cell and Molecular Biology, Vol. 42, No. 4, 2010, pp. 432-441. doi:10.1165/rcmb.2009-0002OC
|
[33]
|
G. Sener, N. Topaloglu, A. O. Sehirli, F. Ercan and N. Gedik, “Resveratrol Alleviates Bleomycin-Induced Lung Injury in Rats,” Pulmonary Pharmacology & Therapeutics, Vol. 20, No. 6, 2007, pp. 642-649.
doi:10.1016/j.pupt.2006.07.003
|
[34]
|
K. R. Trott, T. Herrmann and M. Kasper, “Target Cells in Radiation Pneumopathy,” International Journal of Radiation Oncology Biology Physics, Vol. 58, No. 2, 2004, pp. 463-469. doi:10.1016/j.ijrobp.2003.09.045
|
[35]
|
J. E. Moulder and E. P. Cohen, “Future Strategies for Mitigation and Treatment of Chronic Radiation-Induced Normal Tissue Injury,” Seminars in Radiation Oncology, Vol. 17, No. 2, 2007, pp. 141-148.
doi:10.1016/j.semradonc.2006.11.010
|
[36]
|
N. Hagimoto, K. Kuwano, H. Miyazaki, R. Kunitake, M. Fujita, M. Kawasaki, Y. Kaneko and N. Hara, “Induction of Apoptosis and Pulmonary Fibrosis in Mice in Response to Ligation of Fas Antigen,” American Journal of Respiratory Cell and Molecular Biology, Vol. 17, No. 3, 1997, pp. 272-278.
|
[37]
|
M. A. Sheard, B. Vojtesek, L. Janakova, J. Kovarik and J. Zaloudik, “Up-Regulation of Fas (CD95) in Human P53 wild-Type Cancer Cells Treated with Ionizing Radiation,” International Journal of Cancer, Vol. 73, No. 5, 1997, pp. 757-762.
doi:10.1002/(SICI)1097-0215(19971127)73:5<757::AID-IJC24>3.0.CO;2-1
|
[38]
|
F. Yeung, J. E. Hoberg, C. S. Ramsey, M. D. Keller, D. R. Jones, R. A. Frye, M. W. Mayo, “Modulation of NF-BDependent Transcription and Cell Survival by the SIRT1 Deacetylase,” EMBO Journal, Vol. 23, No. 12, 2004, pp. 2369-2380.
|